Clincosm LogoSign in Get a demo

Reliability and Validity of Urdu Version of Global Physical Activity Questionnaire (GPAQ-U)

Sponsor
Riphah International University (Other)
Overall Status
Completed
CT.gov ID
NCT04862988
Collaborator
(none)
101
Enrollment
1
Location
5.6
Actual Duration (Months)
18.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The GPAQ questionnaire is used to measure the physical activity. In this study, Investigators will observe the reliability and validity of global physical activity questionnaire in Urdu language in Pakistan among students to assess physical activity.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The aim of study is to translate and culturally adapt Global physical Activity Questionnaire (GPAQ) into Urdu language and secondly to investigate the reliability and validity of GPAQ in Pakistan among university students. This study will be cross sectional survey study in which convenience sampling technique will be used.

    The results of study will help to know the validity and reliability of GPAQ in Urdu version among students in Pakistan. The reliability of the questionnaire will be checked through internal consistency and test-retest methods. Internal consistency will be analyzed with Cronbach's alpha value. Test-retest reliability will be assessed using an intra-class correlation coefficient with 100 patients

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    101 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Prospective
    Official Title:
    Reliability and Validity of Urdu Version of Global Physical Activity Questionnaire (GPAQ-U)
    Actual Study Start Date :
    Mar 15, 2021
    Actual Primary Completion Date :
    May 30, 2021
    Actual Study Completion Date :
    Sep 1, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Global Physical Activity Questionnaire (GPAQ) [1st day]

      A measuring instrument to evaluate the duration of vigorous and moderate physical activities that are performed in daily living routine. Each object has a specific code starting from P1 to P16 and then activity is calculated in MET value. For Work and Recreational domains, Moderate MET value is 4.0 and Vigorous MET value is 8.0 while for Transport domains MET value is 4.0

    2. Global Physical Activity Questionnaire (GPAQ) [2nd day]

      A measuring instrument to evaluate the duration of vigorous and moderate physical activities that are performed in daily living routine. Each object has a specific code starting from P1 to P16 and then activity is calculated in MET value. For Work and Recreational domains, Moderate MET value is 4.0 and Vigorous MET value is 8.0 while for Transport domains MET value is 4.0

    Secondary Outcome Measures

    1. International Physical Activity Questionnaire (IPAQ) [1st day]

      A questionnaire for the assessment of population surveillance of physical activity among the adults having age(15-69). Expressed as MET-minutes per week: MET level x minutes of activity/day x days per week

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    15 Years to 69 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Male and female aged over 18 years Pakistani national and native Urdu speakers Able to read and understand Urdu Studying in University level
    Exclusion Criteria:

    Male or female having any disability Any recent illness or any injury

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Riphah International University Faisalabad Punjab, Pakistan Pakistan 38000

    Sponsors and Collaborators

    • Riphah International University

    Investigators

    • Study Chair: Muhammad Kashif, Riphah International University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Riphah International University
    ClinicalTrials.gov Identifier:
    NCT04862988
    Other Study ID Numbers:
    • REC-FSD-00233
    First Posted:
    Apr 28, 2021
    Last Update Posted:
    Sep 14, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Riphah International University
    GPAQ
    reliability,
    Validity
    Urdu

    Study Results

    No Results Posted as of Sep 14, 2021